Inventor of mRNA technology used in the COVID shots says the former president is ignoring the science and refusing to acknowledge he was fooled into supporting the dangerous jab.

Posted BY: Bill | NwoReport

Dr. Robert Malone, the inventor of the mRNA technology in the COVID vaccines, said he can’t support former President Donald Trump as long as he continues defending the experimental shot.

During an interview with Real America’s Voice last week, Trump was asked if he’d acknowledge that the mRNA COVID shots are not as safe or effective as the public was told by the medical establishment.

But Trump doubled down, saying, “I was able to get something approved that, you know, that has proven to have saved a lot of lives. Some people say that I saved 100 million lives worldwide.”

Trending: People are Literally Dropping Dead From the Pfizer Covid Vaccines and The FDA Proposes Annual Covid-19 Vaccines

“You have to understand, there are the pros and cons,” the president went on. “Some reports [say] that it’s the greatest thing that’s ever happened and we saved tens of millions of lives. Then you’ll read other reports [that] say there were some problems with the vaccine …but relatively small numbers.

“But, you know, you have many reports that say the vaccines save tens of millions of lives,” Trump reiterated. “That without the vaccines you would have had a thing … where perhaps 100 million people died.”

Malone was not impressed with Trump’s explanation, endorsing a statement that “this will not get him elected. I am out.”

Malone went on to say that he put together a film segment for Trump spelling out the dangers of the mRNA jab, to no avail.

“I shot a film segment designed to help DJT see the truth. No impact. As I said, it is with regret that I have to agree with Brian. This is different from Mikki’s point. This is DJT’s decision. I disagree,” he tweeted Friday.

Despite Trump’s repeated assurances, VAERS data and many other international peer-reviewed studies and reports are showing the COVID shot has major safety and efficacy issues.